Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lunai Bioworks Inc.RENB · Entity 7981 | Director · 10% owner | June 25, 2024 | June 27, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lunai Bioworks Inc.
Report date June 25, 2024 · Filed June 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase shares of common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.61 · Expires 2034-06-25 | IndirectBy RS Bio ApS | 62.112 |
Reported balance
After 2024-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-25 · Grant · Acquired 62,112 · Balance 62.112 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2024 Filed Jun 27, 2024 22:49 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 62,112 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001731122-24-001029 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 62.112 Underlying: Common stock · 62,112 shares Expires 2034-06-25 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:35 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | OtherWarrant (Right to Buy) · Derivative | 471,699 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001731122-24-000292 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 471,698 Underlying: Common Stock · 471,699 shares Expires 2028-06-26 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:35 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | OtherCommon Stock | 471,699 | $0.53 | $250,000.47 |
DisclosureSEC source: 0001731122-24-000292 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 13,605,297 Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 23:38 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | ConversionSeries A Convertible Preferred Stock · Derivative | 70,126 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001731122-24-000254 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 0 Underlying: Common Stock · 701,260 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Preferred Stock is convertible into Common Stock on a one-for-ten basis. F3 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 23:38 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | ConversionCommon Stock | 701,260 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-24-000254 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 13,133,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share. Read SEC document |
| August 01, 2023 Filed Sep 12, 2023 10:08 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantWarrant (Right to Buy) · Derivative | 350,630 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 350,630 Underlying: Common Stock · 350,630 shares Expires 2028-08-01 F3 · price: Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above. Read SEC document |
| August 01, 2023 Filed Sep 12, 2023 10:08 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantSeries A Convertible Preferred Stock · Derivative | 70,126 | $7.13 Strike: $0.00 | $499,998.38 |
DisclosureSEC source: 0001731122-23-001669 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 70,126 Underlying: Common Stock · 701,260 shares Expires not disclosed F1 · derivative.exercise_price: The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis F2 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date. Read SEC document |
| July 30, 2023 Filed Aug 1, 2023 23:47 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of Common Stock · Derivative | 131,579 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001731122-23-001334 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,579 Underlying: Common Stock · 131,579 shares Expires 2033-07-30 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 00:29 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantWarrant (Right to Buy) · Derivative | 943,397 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001731122-23-001221 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 943,397 Underlying: Common Stock · 943,397 shares Expires 2028-06-26 F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 00:29 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantCommon Stock | 1,886,794 | $0.53 | $1,000,000.82 |
DisclosureSEC source: 0001731122-23-001221 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 12,432,338 Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:39 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantWarrant (Right to Buy) · Derivative | 438,597 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001731122-23-000444 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 438,597 Underlying: Common Stock · 438,597 shares Expires 2028-03-17 F1 · price: Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 01:39 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantCommon Stock | 877,193 | $1.14 | $1,000,000.02 |
DisclosureSEC source: 0001731122-23-000444 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By RS Bio ApS Disclosed balance after: 10,545,544 Read SEC document |
| July 30, 2022 Filed Oct 25, 2022 20:21 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to Purchase Shares of Common Stock · Derivative | 32,609 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001731122-22-001787 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,609 Underlying: Common Stock · 32,609 shares Expires 2032-07-30 Read SEC document |
| June 08, 2022 Filed Jul 18, 2022 10:02 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 128,493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-22-001223 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 0 F2 · kind: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract. F2 · price: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract. Read SEC document |
| June 08, 2022 Filed Jul 18, 2022 10:02 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-22-001223 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Arving ApS Disclosed balance after: 0 F1 · kind: On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid. F1 · price: On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid. Read SEC document |
| May 18, 2022 Filed May 21, 2022 01:32 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 128,493 | $8.00 | $1,027,944.00 |
DisclosureSEC source: 0001731122-22-000958 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 128,493 Read SEC document |
| May 18, 2022 Filed May 21, 2022 01:32 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0001731122-22-000958 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Arving ApS Disclosed balance after: 125,000 Read SEC document |
| December 22, 2021 Filed Jan 4, 2022 22:14 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 3,646 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001731122-22-000010 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,646 Underlying: Common Stock · 3,646 shares Expires 2031-12-22 Read SEC document |
| July 28, 2021 Filed Dec 22, 2021 16:30 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 9,036 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001731122-21-002180 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,036 Underlying: Common Stock · 9,036 shares Expires 2031-07-28 F1 · shares: On July 28, 2021, Mr. Sindlev was granted an option to purchase 9,036 shares of the issuer's common stock, fully vesting on July 28, 2022. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 22:57 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 3,346 | $0.00 Strike: $4.90 | $0.00 |
DisclosureSEC source: 0001731122-19-000524 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346 Underlying: Common Stock · 3,346 shares Expires 2029-07-27 F1 · security: On August 22, 2019, Mr. Sindlev was granted an option to purchase 3,346 shares of the issuer's common stock, vesting on December 10, 2019. Read SEC document |
| July 30, 2019 Filed Aug 2, 2019 01:26 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherWarrant (right to buy) · Derivative | 3,092,307 | $1.30 Strike: $1.30 | $4,019,999.10 |
DisclosureSEC source: 0001731122-19-000423 · ownership.xml · derivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 0 Underlying: Common Stock · 3,092,307 shares Expires 2022-04-21 Read SEC document |
| July 30, 2019 Filed Aug 2, 2019 01:26 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 3,092,307 | $1.30 | $4,019,999.10 |
DisclosureSEC source: 0001731122-19-000423 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 9,668,351 F1 · security: On July 30, 2019, the conditions necessary for the exercise of a warrant to purchase 3,092,307 shares of Issuer's common stock for $1.30 per share pursuant to a notice of exercise dated June 27, 2019 were satisfied and the reporting person was issued 3,092,307 shares of Issuer's common stock. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 18:26 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 31,500 | $6.70 | $211,050.00 |
DisclosureSEC source: 0001731122-19-000310 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,576,044 Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 18:07 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 40,000 | $6.70 | $268,000.00 |
DisclosureSEC source: 0001731122-19-000305 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,544,544 Read SEC document |
| May 29, 2019 Filed Jun 5, 2019 18:06 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 20,000 | $6.60 | $132,000.00 |
DisclosureSEC source: 0001731122-19-000304 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,504,544 Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:05 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 36,200 | $6.61 | $239,282.00 |
DisclosureSEC source: 0001731122-19-000294 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,479,530 Read SEC document |
| May 28, 2019 Filed Jun 5, 2019 18:08 UTC Amendment | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 36,200 | $6.61 | $239,282.00 |
DisclosureSEC source: 0001731122-19-000306 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,484,544 Read SEC document |
| May 24, 2019 Filed Jun 5, 2019 18:05 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 5,014 | $6.25 | $31,337.50 |
DisclosureSEC source: 0001731122-19-000303 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,448,344 Read SEC document |
| May 22, 2019 Filed May 24, 2019 19:39 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 500 | $5.76 | $2,880.00 |
DisclosureSEC source: 0001731122-19-000283 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,443,330 Read SEC document |
| May 21, 2019 Filed May 23, 2019 21:39 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 20,000 | $5.75 | $115,000.00 |
DisclosureSEC source: 0001731122-19-000280 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,442,830 Read SEC document |
| December 27, 2018 Filed Dec 29, 2018 00:11 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherWarrant to Purchase Common Stock · Derivative | 1,307,693 | $1.30 Strike: $1.30 | $1,700,000.90 |
DisclosureSEC source: 0001731122-18-000190 · ownership.xml · derivative · entry 3 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 3,092,307 Underlying: Common Stock · 1,307,693 shares Expires 2022-04-21 F1 · ownership.nature: ApS assigned its holdings in Enochian Biosciences, Inc. to RS Bio ApS. Both entities are wholly owned by Rene Sindlev. Read SEC document |
| December 27, 2018 Filed Dec 29, 2018 00:11 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 1,307,693 | $1.30 | $1,700,000.90 |
DisclosureSEC source: 0001731122-18-000190 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 6,422,830 Read SEC document |
| December 27, 2018 Filed Dec 29, 2018 00:11 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 92,968 | $8.00 | $743,744.00 |
DisclosureSEC source: 0001731122-18-000190 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Bio ApS Disclosed balance after: 5,115,137 Read SEC document |
| September 19, 2018 Filed Nov 8, 2018 02:12 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to Purchase Common Stock · Derivative | 7,840 | $5.74 Strike: $5.74 | $45,001.60 |
DisclosureSEC source: 0001731122-18-000139 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,840 Underlying: Common Stock · 7,840 shares Expires 2028-09-19 Read SEC document |
| May 21, 2018 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseCommon Stock | 1,300 | $5.38 | $6,994.00 |
DisclosureSEC source: 0001731122-18-000140 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 5,022,169 F1 · ownership.nature: On May 21, 2018, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 1,300 shares of common stock of Enochian Biosciences, Inc. in an open market transaction. RS Group ApS subsequently transferred all of its shares to RS Biopharma ApS, an entity controlled by Mr. Sindlev. Read SEC document |
| February 16, 2018 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherWarrant to Purchase Common Stock · Derivative | 250,000 | $2.00 Strike: $2.00 | $500,000.00 |
DisclosureSEC source: 0001731122-18-000141 · ownership.xml · derivative · entry 4 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2019-12-31 Read SEC document |
| February 16, 2018 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherWarrant to Purchase Common Stock · Derivative | 1,000,000 | $1.30 Strike: $1.30 | $1,300,000.00 |
DisclosureSEC source: 0001731122-18-000141 · ownership.xml · derivative · entry 3 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 4,400,000 Underlying: Common Stock · 1,000,000 shares Expires 2022-04-21 Read SEC document |
| February 16, 2018 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 250,000 | $2.00 | $500,000.00 |
DisclosureSEC source: 0001731122-18-000141 · ownership.xml · nonDerivative · entry 2 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 5,020,869 Read SEC document |
| February 16, 2018 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 1,000,000 | $1.30 | $1,300,000.00 |
DisclosureSEC source: 0001731122-18-000141 · ownership.xml · nonDerivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 4,770,869 Read SEC document |
| October 17, 2017 Filed Nov 8, 2018 02:13 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | PurchaseWarrant to Purchase Common Stock · Derivative | 250,000 | $2.00 Strike: $2.00 | $500,000.00 |
DisclosureSEC source: 0001731122-18-000142 · ownership.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By RS Group ApS Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2019-12-31 Read SEC document |
| October 13, 2017 Filed Oct 19, 2017 22:51 UTC | Lunai Bioworks Inc. DDRT · Entity 7981 | PurchaseWarrants to purchase shares of common stock · Derivative | 250,000 | $2.00 Strike: $2.00 | $500,000.00 |
DisclosureSEC source: 0001213900-17-010746 · f4101317sindlev_dandrit.xml · derivative · entry 1 Sindlev Rene · CIK 0001709513 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,650,000 Underlying: Common Stock · 250,000 shares Expires 2019-12-31 F1 · security: On October 13, 2017, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 250,000 warrants to purchase shares of common stock of Dandrit Biotech USA, Inc. in a private transaction. F1 · ownership.nature: On October 13, 2017, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 250,000 warrants to purchase shares of common stock of Dandrit Biotech USA, Inc. in a private transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.